Recent News

• 06.04.2025 - Jefferies 2025 Global Healthcare Conference – Fireside Chat
• 06.04.2025 - Jefferies 2025 Global Healthcare Conference – Fireside Chat
• 05.27.2025 - Assembly Biosciences to Present During the Jefferies 2025 Global Healthcare Conference
• 05.27.2025 - Assembly Biosciences to Present During the Jefferies 2025 Global Healthcare Conference
• 05.27.2025 - Assembly Biosciences to Present During the Jefferies 2025 Global Healthcare Conference
• 05.08.2025 - Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates
• 05.08.2025 - Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates
• 05.08.2025 - Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates
• 05.07.2025 - New Preclinical Data for Assembly Biosciences’ Oral Hepatitis D Virus Entry Inhibitor ABI-6250 and Next-Generation Hepatitis B Virus Capsid Assembly Modulator ABI-4334 Presented at the EASL Congress 2025
• 05.07.2025 - New Preclinical Data for Assembly Biosciences’ Oral Hepatitis D Virus Entry Inhibitor ABI-6250 and Next-Generation Hepatitis B Virus Capsid Assembly Modulator ABI-4334 Presented at the EASL Congress 2025

Recent Filings

• 05.08.2025 - 8-K Current report
• 05.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.08.2025 - EX-99.1 EX-99.1
• 04.23.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.23.2025 - DEF 14A Other definitive proxy statements
• 04.23.2025 - ARS Annual Report to Security Holders
• 04.15.2025 - 4 Statement of changes in beneficial ownership of securities